Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis

NCT05112263 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Tofacitinib
DRUG: Cyclosporine

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh

Collaborators

[object Object]